Healthcare / Medical Care FacilitiesSaudi
$17.04
+0.27 (+1.61%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 25% · confianza 25%
FCF escenarios
weak_data · normalized FCF $258.9M · quality 68.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
44/100
C
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
8/100
SEC 0%
Sin guardar todavía.
Market Cap
$4.3B
P/E
15.8x
↓EV/EBITDA
11.6x
↓ROE
22.4%
↑Gross Margin
24.9%
↓Debt/Equity
0.70
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2024–2025 · 1 años de histórico normalizado
Revenue CAGR
+7.0%
FCF CAGR
-21.2%
FCF margin
14.8%
FCF / Net income
0.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.54B · net income $266.2M · FCF $228.3M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 |
|---|---|---|---|
| Income Statement | |||
| Revenue | $1.54B | $1.54B | $1.44B |
| Net Income | $266.2M | $266.2M | $185.2M |
| EBITDA | $416.5M | $416.5M | $333.3M |
| EPS | 1.06 | 1.06 | 0.74 |
| Gross Margin | 24.9% | 24.9% | 25.2% |
| Operating Margin | 15.8% | 15.8% | 16.5% |
| Net Margin | 17.3% | 17.3% | 12.9% |
| Balance Sheet | |||
| Debt/Equity | 0.70 | 0.70 | 1.04 |
| Current Ratio | 1.10 | 1.10 | — |
| Cash Flow | |||
| Free Cash Flow | $228.3M | $228.3M | $289.5M |
| Returns | |||
| ROE | 22.4% | 22.4% | 22.4% |
| Valuation | |||
| P/E | 15.78 | 15.78 | — |
| EV/EBITDA | 11.62 | 11.62 | — |
| P/B | 3.59 | 3.59 | — |
| Growth & Yield | |||
| Revenue Growth | 7.0% | 7.0% | — |
| EPS Growth | 43.1% | 43.1% | — |
| Dividend Yield | 1.9% | 1.9% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
12.6%
EPS terminal req.
$1.51
Spread vs growth
30.5%
5Y implied EPS CAGR
11.5%
EPS terminal req.
$1.83
Spread vs growth
31.5%
10Y implied EPS CAGR
10.8%
EPS terminal req.
$2.95
Spread vs growth
32.3%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-25.1%
Start / end P/E
31.5x → 16.1x
EPS bridge
0.74 → 1.06
Residual
-21.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.